Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeRemission InductionSalvage TherapyDisease-Free SurvivalStem CellsCyclophosphamideEtoposideHodgkin DiseaseLymphoma, Non-HodgkinCytarabineRecurrenceMyeloablative AgonistsSurvival RateCarmustineHematopoietic Stem Cell MobilizationBone Marrow TransplantationThiotepaGraft vs Host DiseaseSurvival AnalysisBone Marrow PurgingDoxorubicinVincristineHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationPrognosisAmyloidosisRetrospective StudiesHematopoietic Stem CellsAntineoplastic AgentsBusulfanDexamethasoneBoronic AcidsChemotherapy, AdjuvantPyrazinesAntineoplastic Agents, AlkylatingFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedGraft SurvivalIfosfamideLymphoma, FollicularInduction ChemotherapyAntigens, CD34Lymphoma, T-Cell, PeripheralAutograftsLiver TransplantationThalidomideTime FactorsGranulocyte Colony-Stimulating FactorLymphomaLeukapheresisMesenchymal Stem Cell TransplantationCisplatinPodophyllotoxinPrednisoneNeoplasm, ResidualMaintenance ChemotherapyLymphoma, Large B-Cell, DiffuseTransplantation ChimeraLeukemia, Myeloid, AcuteTissue DonorsCord Blood Stem Cell TransplantationCarboplatinMitoxantroneCell TransplantationLymphoma, B-CellIdarubicinMyelodysplastic SyndromesDrug Administration ScheduleKidney TransplantationNeoplasm Recurrence, LocalNeoplasms, Second PrimaryProspective StudiesEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsLeukemia, Plasma CellInfusions, SpinalBlood Component RemovalNeoplasm StagingAdult Stem CellsAntibodies, MonoclonalBreast NeoplasmsFeasibility StudiesImmunosuppressive AgentsNeutropeniaHistocompatibility TestingLeukemia, MyeloidFatal OutcomeNeoplasmsLife Tables